BTS Guidelines for the Management of Community Acquired Pneumonia in Adults
about
Effectiveness of manual therapies: the UK evidence report.Pneumonia: update on diagnosis and managementActivity of telithromycin and comparators against bacterial pathogens isolated from 1,336 patients with clinically diagnosed acute sinusitisAntibiotics for coughing in general practice: a questionnaire study to quantify and condense the reasons for prescribing.Pneumonia in the neutropenic cancer patientIntegrating Antimicrobial Therapy with Host Immunity to Fight Drug-Resistant Infections: Classical vs. Adaptive TreatmentRisk factors for hospital admission in the 28 days following a community-acquired pneumonia diagnosis in older adults, and their contribution to increasing hospitalisation rates over time: a cohort studyQ Fever in French Guiana: Tip of the Iceberg or Epidemiological Exception?Markers of Disease Severity in Patients with Spanish Influenza in the Japanese Armed Forces, 1919-1920Early recognition of the 2009 pandemic influenza A (H1N1) pneumonia by chest ultrasound.The potential anesthetic threats, challenges and intensive care considerations in patients with HIV infection.Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind studyReducing door-to-antibiotic time in community-acquired pneumonia: Controlled before-and-after evaluation and cost-effectiveness analysis.The information and support needs of patients discharged after a short hospital stay for treatment of low-risk Community Acquired Pneumonia: implications for treatment without admissionImproving antibiotic prescribing for adults with community acquired pneumonia: Does a computerised decision support system achieve more than academic detailing alone?--A time series analysis.The Queensland experience of participation in a national drug use evaluation project, Community-Acquired Pneumonia Towards Improving Outcomes Nationally (CAPTION).Evaluation of pneumonia severity and acute physiology scores to predict ICU admission and mortality in patients hospitalized for influenza.Disease Course of Lower Respiratory Tract Infection With a Bacterial CauseEfficacy and safety of levofloxacin in the context of other contemporary fluoroquinolones: a review.Comparison of two guideline-concordant antimicrobial combinations in elderly patients hospitalized with severe community-acquired pneumonia.A decision aid to rule out pneumonia and reduce unnecessary prescriptions of antibiotics in primary care patients with cough and fever.A comparison of comorbidities obtained from hospital administrative data and medical charts in older patients with pneumoniaEfficacy and safety of nemonoxacin versus levofloxacin for community-acquired pneumoniaSwitch therapy in hospitalized patients with community-acquired pneumonia: tigecycline vs. levofloxacin.The comparative development of elevated resistance to macrolides in community-acquired pneumonia caused by Streptococcus pneumoniae.Pulmonary protection.Large scale organisational intervention to improve patient safety in four UK hospitals: mixed method evaluationWhat is the optimal duration of antibiotic therapy?Pneumonia in military trainees: a comparison study based on adenovirus serotype 14 infectionImmunosuppressant dose reduction and long-term rejection risk in renal transplant recipients with severe bacterial pneumoniaClinical and economic burden of community-acquired pneumonia among adults in the Czech Republic, Hungary, Poland and Slovakia.I-ROAD could be efficient in predicting severity of community-acquired pneumonia or healthcare-associated pneumonia.Incidence of community-acquired lower respiratory tract infections and pneumonia among older adults in the United Kingdom: a population-based study.The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia.Assessment of analysis of urinary pneumococcal antigen by immunochromatography for etiologic diagnosis of community-acquired pneumonia in adults.Serum amyloid alpha in parapneumonic effusions.Community-acquired pneumonia on the intensive care unit: secondary analysis of 17,869 cases in the ICNARC Case Mix Programme Database.Amoxicillin is effective against penicillin-resistant Streptococcus pneumoniae strains in a mouse pneumonia model simulating human pharmacokinetics.Early Diagnosis of Pneumonia in Severe Stroke: Clinical Features and the Diagnostic Role of C-Reactive ProteinThe International Community-Acquired Pneumonia (CAP) Collaboration Cohort (ICCC) study: rationale, design and description of study cohorts and patients.
P2860
Q21203702-70A2A115-4F02-4D99-8244-5E0B4246F80DQ22242097-C9AFEFCE-C14D-479C-A636-D11304BF8F1FQ24798440-560A339A-65BB-4E5E-89A7-E377B6F89C1FQ24803508-B7169E1A-262E-4F09-ACD2-D59DF05DEB61Q26827758-D86B7487-2206-42A6-AAFB-A60D7F5F9820Q28551361-40FF005F-AA26-4656-AB5F-B96405015333Q28604186-7DDA7382-2094-4E7B-8B6C-DBA310B2BF93Q29353616-86CF10F0-9422-450E-A843-EBAA9EB1B5ADQ30400151-9E43CBB7-9980-4B6E-9C25-B8842568A02FQ30413170-30DF4594-4F70-4C16-BAE5-EB8C18D12AD3Q30429050-CFB317CB-2423-45D5-A2BC-AB05D948BDCBQ30477432-77ECB3E3-1477-48F3-B22E-866F8E5DAA3BQ30480791-A827A4D4-D1C0-499A-B347-3A89DEA64A83Q33355839-0648E6EB-F1F2-4407-A3DF-0ECB6763EFF0Q33356262-B4B3597A-D499-42BC-A899-B2D725178A14Q33489098-75596FAB-137E-4FBF-B684-274DDBA0C609Q33539788-F562D0BB-75CC-47FF-8168-E6E28E4CB322Q33557062-AED8B833-F7CC-41D0-8D42-32190D021E90Q33739099-1E0462C4-D7FE-430F-9BE1-81FCBB0A8FDAQ33790704-C55817DF-94E1-45DC-9F6C-597D43DFCE9CQ33899010-F9C13EE1-5FA0-4D72-916B-0FC59DCF048CQ33903546-168702C0-EFF8-42B3-82E5-C59516387E79Q34151093-11E11D3D-93B4-4AF9-B832-F9E3C813EE81Q34343859-1AECC624-FACA-46E4-9086-082A03CA6282Q34353808-877E8AA8-6711-41B2-8092-ED859DD8CC78Q34525400-98CA3110-B10F-480D-850F-D0C2A417A5ABQ34550841-A35F8627-FB3E-419D-96CA-A18517ECDC38Q34669737-99BD3D38-E567-4BE9-8A62-5ED262E32761Q34834043-313D5144-B8D7-419A-BDF7-D815BB6E370DQ34929119-493BB990-9500-48F2-AC06-202F2C0C8BA5Q34937466-FDA0D112-EA7A-4520-8D62-8BD730F545D2Q34953557-887E7037-714C-411B-A4C1-BAD3DDA1C76AQ34990544-A20854CD-1C6B-4C1A-96F7-3C858D2D60BBQ34999299-414EB34F-4963-4AC9-9F59-DD9B1D0DA08DQ35075184-6D8025C1-20CD-434A-A913-5E9CA4457A93Q35184494-3E0C75EC-1CA6-42AD-9FB8-E850C76F694DQ35578955-CD6A2CBE-A6B5-4B7C-9ED3-1C2725570D8FQ35635640-6DA8435B-CCEA-4DC7-9081-0E73625A10BFQ35944058-D6380751-89D0-4CDC-8E96-38714029827CQ35981786-B59759C8-4578-46EF-B6F7-9B6FDE71C84E
P2860
BTS Guidelines for the Management of Community Acquired Pneumonia in Adults
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
BTS Guidelines for the Management of Community Acquired Pneumonia in Adults
@ast
BTS Guidelines for the Management of Community Acquired Pneumonia in Adults
@en
BTS Guidelines for the Management of Community Acquired Pneumonia in Adults
@nl
type
label
BTS Guidelines for the Management of Community Acquired Pneumonia in Adults
@ast
BTS Guidelines for the Management of Community Acquired Pneumonia in Adults
@en
BTS Guidelines for the Management of Community Acquired Pneumonia in Adults
@nl
prefLabel
BTS Guidelines for the Management of Community Acquired Pneumonia in Adults
@ast
BTS Guidelines for the Management of Community Acquired Pneumonia in Adults
@en
BTS Guidelines for the Management of Community Acquired Pneumonia in Adults
@nl
P2860
P3181
P1433
P1476
BTS Guidelines for the Management of Community Acquired Pneumonia in Adults
@en
P2860
P304
P3181
P356
10.1136/THORAX.56.SUPPL_4.IV1
P407
P478
56 Suppl 4
P577
2001-12-01T00:00:00Z